US national survey reports alarming increase in use of e-cigarettes by youthUse increased by 78% in high schoolers and by 48% in middle schoolers from 2017 to 2018 Webinar on demand: Asthma & COPD - medical devices that will change your practice New Interim Order will permit import of alternate epinephrine autoinjector during EpiPen shortage Auvi-Q 0.3 mg autoinjector expected to be available in pharmacies by September 7th New, shorter therapy more effective for latent TB, landmark study finds Antimicrobial allergy: assessing and managing patients with hypersensitivity reactions Patients with cystic fibrosis doing better in Canada than elsewhere, study finds Getting influenza raises heart attack risk, especially in seniors: study Cardiovascular risk peaks 30 days after starting LABA or LAMA therapy in COPD Close monitoring for cardiovascular symptoms recommended for new users of LABAs or LAMAs Canadian Thoracic Society issues COPD pharmacotherapy update Provides evidence-based recommendations for pharmacologic management of COPD New Canadian Thoracic Society statement focuses on severe asthma Provides guidance on management, including the role of new and emerging therapies First Previous 36 37 38 39 40 Next Last
